Comparison of the difference between Cipralex and Seroxat tablets and which is better for depression treatment

Both Cipralex and Seroxat are used to treat depression and various anxiety disorders, and both belong to the selective serotonin reuptake inhibitor (SSRI) class. However, they differ in the active ingredient they contain, leading to differences in effectiveness and potential side effects.

Cipralex Tablets Ingredients

Cipralex tablets contain the active ingredient escitalopram. Escitalopram is the S-enantiomer of citalopram. It works by increasing levels of serotonin, a neurotransmitter in the brain that helps regulate mood and anxiety. Escitalopram is generally more selective for serotonin and may be associated with fewer side effects in some people than some other SSRIs.

Seroxat Tablets Ingredients

Seroxat tablets contain the active ingredient paroxetine. Paroxetine is also a selective serotonin reuptake inhibitor (SSRI) that works by blocking the reuptake of serotonin into nerve cells, increasing the amount of serotonin available in the brain. Paroxetine differs from escitalopram in its chemical structure and other pharmacological properties.

Information about Cipralex tablets

Drug class: Antidepressants

Drug classification: Selective serotonin reuptake inhibitors (SSRIs)

Pharmaceutical form: Tablets

Pharmaceutical family: Central nervous system drugs

Active ingredient: Escitalopram

Information about Seroxat tablets

Drug class: Antidepressants

Drug class: Selective serotonin reuptake inhibitors (SSRIs)

Pharmaceutical form: Tablets

Pharmaceutical family: Central nervous system drugs

Active ingredient: Paroxetine

Author Name: Dr. Rawan Mossad Elsaed

Scientific Degree: Pharmacist

Country: Egypt

Dr. Rawan Mosaad El-Saeed is a clinical pharmacist and medical content reviewer holding a Bachelor of Pharmacy degree from Horus University in Egypt. She has hands-on community pharmacy experience in providing medication therapy counseling, monitoring drug-drug interactions, and ensuring patient adherence to safe usage protocols. She specializes in authoring and fact-checking pharmaceutical guides and simplifying clinical pharmacology based on the latest evidence-based guidelines and internationally accredited references, dedicated to delivering accurate, reliable, and safe healthcare information for readers.

Published Date: 21 April 2025